News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Vincent Rajkumar: 3 Possible Entities of Solitary Plasmacytoma with differing Prognosis in the Differential Diagnosis
Vincent Rajkumar/X
May 12, 2025, 10:53

Vincent Rajkumar: 3 Possible Entities of Solitary Plasmacytoma with differing Prognosis in the Differential Diagnosis

Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared an article on X:

“Solitary plasmacytoma.

One lesion, but 3 possible entities with differing prognosis in the differential diagnosis.

Outcomes and management.”

Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes.

Authors: Charalampos Charalampous, Jean-Sebastien Claveau, Prashant Kapoor, Moritz Binder, Francis K. Buadi, Joselle Cook, David Dingli, Angela Dispenzieri, Amie L. Fonder, Morie A. Gertz, Wilson Gonsalves, Suzanne R. Hayman, Miriam A. Hobbs, Yi L. Hwa, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar.

You can read the Full Article on Journal of Blood Advances.

Vincent Rajkumar: 3 Possible Entities of Solitary Plasmacytoma with differing Prognosis in the Differential Diagnosis

More posts featuring Vincent Rajkumar.

Amie L Fonder Angela Dispenzieri cancer Charalampos Charalampous David Dingli diagnosis fight against cancer Francis K. Buadi Global fight against cancer Jean-Sebastien Claveau Joselle Cook Martha Q Lacy Mayo Clinic Miriam A Hobbs Morie A Gertz Moritz Binder Nelson Leung OncoDaily Oncology Prashant Kapoor prognosis Rahma Warsame Robert A. Kyle Rochester S Vincent Rajkumar Shaji K. Kumar Solitary Plasmacytoma Suzanne R Hayman Taxiarchis Kourelis Vincent Rajkumar Wilson Gonsalves Yi L. Hwa Yi Lin
Special Coverage
Blog
Aug 3, 2025, 20:47
Debanjan Kundu: I am Privileged to Have Visited This Centuries-Old Hospital as an AROI WB Young Oncology Fellow
Insight
Aug 3, 2025, 20:42
Armando Orlandi։ Redefining Who Should Consider Preventive Breast Surgery
Blog
Aug 3, 2025, 20:29
Al-Ola A Abdallah: 2nd Regional ‪2025 Immune Cell Effector Therapy Symposium Conference
Blog
Aug 3, 2025, 20:04
How the Latest Evidence Is Used in EGFR-Mutated NSCLC Treatment - NCODA
Blog
Aug 3, 2025, 19:45
Miguel Bronchud: Primary Tumor Surgery Lymphadenectomy?
Blog
Aug 3, 2025, 19:41
Hung Trinh: First-of-its-kind Clinical Trial - Reprogramming Stem Cells to Create Renewable Cancer-fighting T Cells
Insight
Aug 3, 2025, 19:32
Amol Akhade: Understanding the Hidden Rules of Trial Design
Blog
Aug 3, 2025, 19:26
Dewi Vernerey: The Results of the ASTER 70s Trial
Insight
Aug 3, 2025, 19:25
Patrick Hwu։ Why Do Some Gastrointestinal Cancers Become Resistant to KRAS-targeted Therapies?
Insight
Aug 3, 2025, 19:18
Wafaa M Rashed: Polygenic Risk Score for Cancer in African Population
Insight
Aug 3, 2025, 18:54
Ali Mortezaei: Our Study on the Cover of the Journal of Neurosurgery Publishing Group Focus
Blog
Aug 3, 2025, 18:29
Bridging the Gap in the Diagnosis and Management of Lung Cancer - Hellenic Association of Lung Cancer